This is in contrast to effects seen upon Ephrin A1 binding to EphA2 which has been reported to block EphA2 Ser897 and Akt Ser129, resulting in inhibition of migration/invasion of glioma and prostate cancer cells respectively [12, 15]. Here, AKT1 is linked to central nervous system cancer.